Session I: Inflammation and cancer

Session II: Cancer initiation, senescence and stemness

1) Marcus Ruscetti -  UMass, USA
2) Kara Britt -  Peter Mac, Australia
3) Heidi Neubeuer -  Vetmeduni Vienna, Austria
4) Mathias Ernst -  ONJCRI, Australia
5) TBA talk to be selected from submitted abstracts

Session III: Immunometabolism, and signalling (incl. epigenetics)

1) Kathy Borden –  University of Montreal, Canada
2) Ali Shilatifard -  Northwestern  University, USA
3) Dong-Er Zhang -  UCSD, USA
4) Nancy Reich -  Stony Brook, USA
5) Diana Saleiro - Northwestern University, USA

Session IV: Cytokines as predictors of therapeutic response

1) Ian Parish  -  Peter MacCallum Cancer Centre, Australia
2) Thomas Gebhardt -  Doherty Institute, Australia
3) Jane Oliaro -  Peter MacCallum Cancer Centre, Australia
4) Florian Wiede - Monash University, Australia
5) Jody Haigh - University of Manitoba, Canada
 

Session V: ILCs and innate immunity (incl. unique immune subsets)

1) Andreas Behren -  ONJCRI, Australia
2) Jadwiga Jablonska -University of Essen, Germany
3) Chiara Romagnani - DRFZ and Charite Berlin, Germany
4) Julien Marie - INSERM, France

Session VI: Enhancing cellular immunogenicity in therapy

1) Paul Hertzog -  Hudson Institute, Australia
2) Belinda Parker -  Peter MacCallum Cancer Centre, Australia
3) Tony Tiganis -  Monash University, Australia
4) TBA talk to be selected from submitted abstracts
5) TBA talk to be selected from submitted abstracts

Session VII: Cancer Immunotherapy & Autoimmunity 

1) Stephanie Watowich - MD Anderson, USA
2) Yong Wan - Emory University, USA
3) Alexandra-Chloe Villani - Harvard University, USA
4) Nicole Campbell - Monash University, Australia

Session VIII: One Heath (eg lessons from cytokines in other diseases)

1) David Brooks -  University of Toronto, Canada
2) Chris Overall -  University British Columbia, Canada
3) Ori Scott -  Hospital for Sick Children, Toronto
4) Eleanor Fish -  University of Toronto & UHN, Canada
5) TBA talk to be selected from submitted abstracts